These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3755385)

  • 1. Methods for eliminating interferences in digoxin immunoassays caused by digoxin-like factors.
    Graves SW; Sharma K; Chandler AB
    Clin Chem; 1986 Aug; 32(8):1506-9. PubMed ID: 3755385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of incubation time and temperature on the interference of digoxin-like immunoreactive substances in digoxin immunoassays.
    Yannakou L; Diamandis EP; Souvatzoglou A
    Ther Drug Monit; 1987 Dec; 9(4):461-3. PubMed ID: 3424414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A physician's office-based digoxin assay (Seralyzer) evaluated for interference by endogenous digoxin-like immunoreactive factors.
    Matheke ML; Valdes R
    Ann Clin Lab Sci; 1989; 19(3):168-74. PubMed ID: 2658726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous digoxin-like immunoreactive factors eliminated from serum samples by hydrophobic silica-gel extraction and enzyme immunoassay.
    Skogen WF; Rea MR; Valdes R
    Clin Chem; 1987 Mar; 33(3):401-4. PubMed ID: 3545537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin-like immunoreactivity in serum from neonates and infants reduced by centrifugal ultrafiltration and fluorescence polarization immunoassay.
    Ray JE; Crisan D; Howrie DL
    Clin Chem; 1991 Jan; 37(1):94-8. PubMed ID: 1988216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference of endogenous digoxin-like immunoreactive factors in serum digoxin measurement is minimized in a new turbidimetric digoxin immunoassay on ADVIA 1650 analyzer.
    Datta P; Dasgupta A
    Ther Drug Monit; 2004 Feb; 26(1):85-9. PubMed ID: 14749555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of human serum with sulfosalicylic acid structurally alters digoxin and endogenous digoxin-like immunoreactive factor.
    Qazzaz HM; Goudy S; Miller JJ; Valdes R
    Ther Drug Monit; 1995 Feb; 17(1):53-9. PubMed ID: 7725377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temperature-dependent immunoreactive assay to screen for digoxin-like immunoreactive factor(s).
    Guédeney X; Chanez C; Grenier A; Scherrmann JM
    Clin Chem; 1991 Nov; 37(11):1900-4. PubMed ID: 1718632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved interassay correlation of digoxin results in patients with and without renal failure by elimination of digoxin-like immunoreactive factors.
    Skogen WF; Rea MR; Valdes R
    Clin Chem; 1987 Jun; 33(6):837-9. PubMed ID: 3594830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked digoxin-like immunoreactive factor interference with an enzyme immunoassay.
    Karboski JA; Godley PJ; Frohna PA; Horton MW; Reitmeyer WJ
    Drug Intell Clin Pharm; 1988 Sep; 22(9):703-5. PubMed ID: 3063480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialyzability and binding of digoxin-like immunoreactive factors (DLIF) with serum macromolecules in uremic patients on hemodialysis.
    Dasgupta A; Peng Y
    Life Sci; 1991; 49(22):1603-9. PubMed ID: 1943464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the specificity of digoxin immunoassays.
    Valdes R
    Wien Klin Wochenschr Suppl; 1992; 191():55-9. PubMed ID: 1509756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay of digoxin in serum using monoclonal antibodies and assessment of interference by digoxin-like immunoreactive substances.
    Loucari-Yiannakou E; Yiannakou L; Souvatzoglou A; Diamandis EP
    Ther Drug Monit; 1990 Mar; 12(2):195-200. PubMed ID: 2315977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Criteria for identifying endogenous compounds as digoxin-like immunoreactive factors in humans.
    Lau BW; Valdes R
    Clin Chim Acta; 1988 Jun; 175(1):67-77. PubMed ID: 2844442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous digoxin-like immunoreactive factors (DLIF) as measured by the CEDIA digoxin assay and a fluorescence polarization immunoassay.
    Schlebusch H; Jarausch J; Domke I
    Wien Klin Wochenschr Suppl; 1992; 191():59-66. PubMed ID: 1509757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous digoxin-immunoactive factor in human subjects.
    Valdes R
    Fed Proc; 1985 Sep; 44(12):2800-5. PubMed ID: 3839758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antibody specificity on results of selected digoxin immunoassays among various clinical groups.
    Datta P; Xu L; Malik S; Landicho D; Ferreri L; Halverson K; Roby PV; Zebelman AM; Kenny MA
    Clin Chem; 1996 Mar; 42(3):373-9. PubMed ID: 8598098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New enzyme-linked immunosorbent digoxin assay on the ADVIA IMS 800i system is virtually free from interference of endogenous digoxin-like immunoreactive factors.
    Dasgupta A; Kang E; Datta P
    Ther Drug Monit; 2005 Apr; 27(2):139-43. PubMed ID: 15795642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous digoxin-like immunoreactive factor (DLIF) serum concentrations are decreased in manic bipolar patients compared to normal controls.
    Grider G; El-Mallakh RS; Huff MO; Buss TJ; Miller J; Valdes R
    J Affect Disord; 1999 Aug; 54(3):261-7. PubMed ID: 10467969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excretion of endogenous digoxin-like immunoreactive factors in human urine is a function of urine flow rate.
    Siegfried BA; Valdes R
    Clin Chem; 1988 May; 34(5):960-4. PubMed ID: 3370798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.